| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 443.30M | 422.90M | 437.00M | 448.90M | 379.20M |
| Gross Profit | 29.30M | 181.50M | 177.00M | 36.30M | 27.40M |
| EBITDA | 74.70M | 74.50M | 62.90M | 63.10M | 46.00M |
| Net Income | 29.00M | 24.60M | 15.50M | 21.30M | 19.00M |
Balance Sheet | |||||
| Total Assets | 694.60M | 695.00M | 668.70M | 585.70M | 592.70M |
| Cash, Cash Equivalents and Short-Term Investments | 125.30M | 139.30M | 110.80M | 83.90M | 108.80M |
| Total Debt | 239.80M | 261.00M | 234.90M | 145.40M | 160.10M |
| Total Liabilities | 366.00M | 387.00M | 367.10M | 282.10M | 302.30M |
| Stockholders Equity | 328.60M | 308.00M | 301.60M | 303.60M | 290.40M |
Cash Flow | |||||
| Free Cash Flow | 42.30M | 40.30M | 36.30M | 32.10M | 25.10M |
| Operating Cash Flow | 48.00M | 46.40M | 41.20M | 37.70M | 31.30M |
| Investing Cash Flow | -14.00M | -19.30M | -83.80M | -30.70M | -53.00M |
| Financing Cash Flow | -49.10M | -13.90M | 33.20M | 1.20M | 29.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | £78.51M | 11.34 | 16.76% | ― | -3.41% | 58.10% | |
67 Neutral | £261.66M | 66.05 | 3.10% | 2.19% | 12.73% | -26.74% | |
63 Neutral | £743.98M | 23.64 | 8.34% | 2.09% | 4.82% | 17.76% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £283.08M | 51.03 | 6.24% | 1.89% | 9.13% | -47.18% | |
54 Neutral | £206.22M | -4.11 | -31.21% | ― | -7.62% | 5.48% | |
54 Neutral | £107.04M | -33.50 | -5.90% | ― | -2.20% | 68.24% |